These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 53924)

  • 1. Canine marrow grafts in donor-recipient combinations with one-way nonstimulation in mixed lymphocyte culture.
    Kolb HJ; Rieder I; Grosse-Wilde H; Scholz S; Kolb H; Wallner B; Netzel B; Albert ED; Thierfelder S
    Transplant Proc; 1975 Dec; 7(4):461-4. PubMed ID: 53924
    [No Abstract]   [Full Text] [Related]  

  • 2. Marrow grafts between canine littermates showing one-way nonstimulation in mixed leukocyte culture.
    Storb R; Weiden PL; Schroeder ML; Graham TC
    Transplant Proc; 1975 Dec; 7(4):459-60. PubMed ID: 824
    [No Abstract]   [Full Text] [Related]  

  • 3. Graft-versus-host disease (GVHD) following marrow grafts from DLA-matched canine littermates.
    Kolb HJ; Rieder I; Grosse-Wilde H; Bodenberger U; Scholz S; Kolb H; Schäffer E; Thierfelder S
    Transplant Proc; 1979 Mar; 11(1):507-10. PubMed ID: 156428
    [No Abstract]   [Full Text] [Related]  

  • 4. Major and minor histocompatibility systems in man and their importance in bone marrow transplantation.
    van Rood JJ; van Leeuwen A
    Transplant Proc; 1976 Sep; 8(3):429-36. PubMed ID: 62433
    [No Abstract]   [Full Text] [Related]  

  • 5. Marrow grafts between unrelated dogs homozygous and identical for DLA antigens.
    Storb R; Weiden PL; Graham TC; Lerner KG; Thomas ED
    Transplant Proc; 1977 Mar; 9(1):281-3. PubMed ID: 17195
    [No Abstract]   [Full Text] [Related]  

  • 6. Marrow grafts in LD--SD typed dogs treated with cyclophosphamide.
    Kolb HJ; Rieder I; Gross-Wilde H; Abb J; Albert E; Kolb H; Schäffer E; Thierfelder S
    Transplant Proc; 1976 Dec; 8(4):555-9. PubMed ID: 11586
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance of major human histocompatibility determinants in clinical bone marrow transplantation.
    Hansen JA; O'Reilly RJ; Good RA; Dupont B
    Transplant Proc; 1976 Dec; 8(4):581-9. PubMed ID: 63170
    [No Abstract]   [Full Text] [Related]  

  • 8. One-way nonstimulation of mixed leukocyte culture in canine families.
    Schroeder ML; Gluckman E; Storb R; Thomas ED
    Transplant Proc; 1975 Sep; 7(3):395-8. PubMed ID: 51524
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
    Neithammer D; Goldmann SF; Haas RJ; Dietrich M; Flad HD; Fliedner TM; Kleihauer E
    Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594
    [No Abstract]   [Full Text] [Related]  

  • 10. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
    Schwarzinger I; Raff RF; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum FR; Schuening F; Storb R
    Bone Marrow Transplant; 1994 Mar; 13(3):303-9. PubMed ID: 8199572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs.
    Thomas ED; Bryant JI; Buckner CD; Clift RA; Fefer A; Fialkow PJ; Funk DD; Neiman PE; Rudolph RH; Slichter SJ; Storb R
    Trans Assoc Am Physicians; 1971; 84():248-61. PubMed ID: 4151544
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of engraftment and graft-versus-host disease after canine marrow transplantation. Two phenomena linked to but not exclusively determined by known antigens of the major histocompatibility complex.
    Storb R; Weiden PL; Graham TC; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):113-8. PubMed ID: 24904
    [No Abstract]   [Full Text] [Related]  

  • 13. Engraftment of allogeneic dog bone marrow.
    Vriesendorp HM; Zurcher C; van Bekkum DW
    Transplant Proc; 1975 Dec; 7(4):465-8. PubMed ID: 825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marrow grafts between canine litter-mates homozygous or heterozygous for lymphocyte-defined histocompatibility antigens.
    Storb R; Weiden PL; Schroeder ML; Graham TC; Lerner KG; Thomas ED
    Transplantation; 1976 Apr; 21(4):299-306. PubMed ID: 7864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matching for donor--host compatibility for bone marrow transplantation.
    Amos DB
    Transplant Proc; 1976 Dec; 8(4):687-92. PubMed ID: 11597
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow transplantation: introduction.
    Mathé G; Oldham R
    Transplant Proc; 1974 Dec; 6(4):333-4. PubMed ID: 4155149
    [No Abstract]   [Full Text] [Related]  

  • 17. The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model.
    Levey RH
    Transplant Proc; 1972 Dec; 4(4):565-6. PubMed ID: 4405148
    [No Abstract]   [Full Text] [Related]  

  • 18. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular factors. Immunologic tolerance: irradiation and bone marrow transplantation in induction of canine allogeneic unresponsiveness.
    Rapaport FT; Bachvaroff RJ; Watanabe K; Hirasawa H; Cannon FD; Mollen N; Blumenstock DA; Ayvazian JH; Ferrebee JW
    Transplant Proc; 1977 Mar; 9(1):891-4. PubMed ID: 17203
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.